Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free GLUE Stock Alerts

Monte Rosa Therapeutics (GLUE) Short Interest Ratio & Short Volume

Monte Rosa Therapeutics logo
$19.27 -0.12 (-0.64%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Monte Rosa Therapeutics Short Interest Overview

As of May 15, 2026, Monte Rosa Therapeutics (GLUE) had a short interest of 14.96 million shares sold short, representing 18.92% of the public float. This marks a -1.19% decrease in short interest since the prior report. The short interest ratio (days to cover) is 20.6, meaning it would take 20.6 days of the average trading volume of 1.32 million shares to cover all short positions.

Current Short Interest
14,962,299 shares
Previous Short Interest
15,142,638 shares
Change Vs. Previous Month
-1.19%
Dollar Volume Sold Short
$271.57 million
Short Interest Ratio
20.6 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
84,480,000 shares
Short Percent of Float
18.92%
Today's Trading Volume
349,266 shares
Average Trading Volume
1,321,768 shares
Today's Volume Vs. Average
26%
Short Selling Monte Rosa Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GLUE Short Interest Over Time

GLUE Days to Cover Over Time

GLUE Percentage of Float Shorted Over Time

Monte Rosa Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202614,962,299 shares $271.57 million -1.2%18.9%20.63 $18.15
4/30/202615,142,638 shares $289.98 million -4.4%19.2%17.85 $19.15
4/15/202615,837,633 shares $288.72 million +18.2%21.3%15.99 $18.23
3/31/202613,398,925 shares $220.41 million +22.2%18.0%8.81 $16.45
3/13/202610,964,393 shares $175.65 million +8.4%14.7%12.64 $16.02
2/27/202610,115,500 shares $179.55 million +8.4%16.6%10.7 $17.75
2/13/20269,330,612 shares $167.20 million +21.8%15.3%9.28 $17.92
1/30/20267,664,016 shares $157.27 million +38.0%12.6%6.73 $20.52
1/15/20265,554,802 shares $133.76 million -34.3%9.1%1.37 $24.08
12/31/20258,454,052 shares $132.56 million +20.8%13.9%5.79 $15.68
12/15/20257,001,428 shares $115.17 million -0.1%11.5%9.46 $16.45
11/28/20257,006,369 shares $113.54 million -5.3%11.5%8.62 $16.21
11/14/20257,396,896 shares $106.22 million -7.4%12.1%6.8 $14.36
10/31/20257,988,754 shares $102.66 million -1.2%13.1%7.64 $12.85
10/15/20258,080,000 shares $89.77 million +3.2%21.7%6.5 $11.11
9/30/20257,830,000 shares $58.02 million -5.0%16.9%7.3 $7.41
9/15/20258,240,000 shares $57.10 million No Change17.8%8.2 $6.93
8/31/20258,240,000 shares $39.55 million -1.0%17.8%20.2 $4.80
8/15/20258,320,000 shares $38.11 million -4.4%18.0%18.9 $4.58
7/31/20258,700,000 shares $43.07 million -2.5%18.8%19.3 $4.95
7/15/20258,920,000 shares $46.65 million +0.7%19.4%20.1 $5.23
6/30/20258,860,000 shares $39.96 million -0.1%19.3%16.4 $4.51
6/15/20258,870,000 shares $43.55 million +9.8%19.3%15 $4.91
5/31/20258,080,000 shares $33.45 million -3.8%17.6%12.2 $4.14
5/15/20258,400,000 shares $32.51 million +6.6%18.3%12.4 $3.87
4/30/20257,880,000 shares $38.69 million +4.7%17.1%11.6 $4.91
4/15/20257,530,000 shares $33.36 million +39.2%16.4%10.4 $4.43
3/31/20255,410,000 shares $25.10 million -23.0%11.8%6.9 $4.64
3/15/20257,030,000 shares $44.08 million -12.6%15.3%8.7 $6.27
2/28/20258,040,000 shares $44.22 million +0.1%17.5%8.2 $5.50
2/15/20258,030,000 shares $54.44 million -0.5%17.5%7.6 $6.78
1/31/20258,070,000 shares $53.75 million -7.9%17.6%7 $6.66
1/15/20258,760,000 shares $54.66 million -4.2%19.1%3.2 $6.24
12/31/20249,140,000 shares $63.43 million +8.8%19.9%3.3 $6.94
12/15/20248,400,000 shares $63.50 million -24.0%18.2%3.2 $7.56
11/30/202411,050,000 shares $114.48 million -0.9%23.9%4.5 $10.36
11/15/202411,150,000 shares $86.30 million +42.2%24.1%5.1 $7.74
10/31/20247,840,000 shares $66.64 million +49.9%17.0%3.8 $8.50
10/15/20245,230,000 shares $26.78 million +19.4%11.7%15 $5.12
9/30/20244,380,000 shares $23.21 million +33.9%9.8%12.2 $5.30
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
9/15/20243,270,000 shares $19.88 million +6.9%7.5%11.7 $6.08
8/31/20243,060,000 shares $18.88 million +9.7%7.2%12.9 $6.17
8/15/20242,790,000 shares $13.67 million +0.4%6.5%11.9 $4.90
7/31/20242,780,000 shares $12.57 million -2.8%6.5%11.2 $4.52
7/15/20242,860,000 shares $11.98 million +11.7%6.7%12.2 $4.19
6/30/20242,560,000 shares $9.57 million +29.3%6.0%11.8 $3.74
6/15/20241,980,000 shares $7.58 million +3.7%4.6%9.9 $3.83
5/31/20241,910,000 shares $7.87 million -17.3%5.0%10.3 $4.12
5/15/20242,310,000 shares $12.08 million +20.9%6.0%13.8 $5.23
4/30/20241,910,000 shares $10.16 million +2.1%6.0%13.7 $5.32
4/15/20241,870,000 shares $12.29 million +11.3%5.9%14.2 $6.57
3/31/20241,680,000 shares $11.84 million -8.2%5.3%11.2 $7.05
3/15/20241,830,000 shares $11.73 million -0.5%5.8%11.2 $6.41
2/29/20241,840,000 shares $11.65 million -7.1%5.8%9.6 $6.33
2/15/20241,980,000 shares $10.95 million +3.7%6.3%9.6 $5.53
1/31/20241,910,000 shares $10.12 million -2.6%6.1%9.1 $5.30
1/15/20241,960,000 shares $11.76 million -4.9%6.2%8 $6.00
12/31/20232,060,000 shares $11.64 million -12.7%6.5%6.6 $5.65
12/15/20232,360,000 shares $11.80 million -20.5%7.5%7.7 $5.00
11/30/20232,970,000 shares $9.21 million -2.9%9.4%10.7 $3.10
11/15/20233,060,000 shares $11.26 million -8.7%9.7%12.1 $3.68
10/31/20233,350,000 shares $11.39 million -10.2%10.8%12.4 $3.40
10/15/20233,730,000 shares $18.02 million -6.8%12.1%15.6 $4.83
9/30/20234,000,000 shares $19.16 million +4.4%12.9%25.8 $4.79
9/15/20233,830,000 shares $23.02 million +7.9%12.4%25.8 $6.01
8/31/20233,550,000 shares $20.84 million +14.2%11.5%23.3 $5.87
8/15/20233,110,000 shares $20.46 million +11.1%10.0%19 $6.58
7/31/20232,800,000 shares $19.80 million +6.5%7.0%19.3 $7.07
7/15/20232,630,000 shares $18.33 million +1.9%6.6%14.1 $6.97
6/30/20232,580,000 shares $17.67 million +5.7%6.5%12.3 $6.85
6/15/20232,440,000 shares $18.03 million +6.6%6.1%11.9 $7.39
5/31/20232,290,000 shares $16.90 million No Change5.8%12 $7.38
5/15/20232,290,000 shares $13.40 million +2.2%5.8%13.5 $5.85
4/30/20232,240,000 shares $10.17 million -10.0%5.6%13.5 $4.54
4/15/20232,490,000 shares $17.06 million +2.9%6.3%16.5 $6.85
3/31/20232,420,000 shares $18.85 million +9.0%6.1%17.2 $7.79
3/15/20232,220,000 shares $14.50 million -3.1%5.6%15.9 $6.53
2/28/20232,290,000 shares $13.92 million -8.0%5.9%15.8 $6.08
2/15/20232,490,000 shares $16.98 million -33.2%6.4%17.1 $6.82
1/31/20233,730,000 shares $27.60 million -0.8%9.6%22.6 $7.40
1/15/20233,760,000 shares $29.37 million -13.4%9.7%25.9 $7.81
12/30/20224,340,000 shares $33.03 million +1.4%11.2%27.7 $7.61
12/15/20224,280,000 shares $40.57 million -1.8%11.1%24 $9.48
11/30/20224,360,000 shares $36.97 million -6.6%14.6%20.1 $8.48
11/15/20224,670,000 shares $43.99 million -4.3%15.7%20.7 $9.42
10/31/20224,880,000 shares $44.90 million +1.2%16.4%21.3 $9.20
10/15/20224,820,000 shares $37.45 million -6.2%16.2%21.3 $7.77
9/30/20225,140,000 shares $41.99 million +4.5%17.3%23 $8.17
9/15/20224,920,000 shares $39.26 million -3.3%16.6%24.2 $7.98
8/31/20225,090,000 shares $40.31 million +6.5%17.2%26.3 $7.92
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
8/15/20224,780,000 shares $47.51 million +3.5%16.1%23.4 $9.94
7/31/20224,620,000 shares $41.90 million No Change15.6%23.8 $9.07
7/15/20224,620,000 shares $47.36 million -0.9%15.6%23.8 $10.25
6/30/20224,660,000 shares $45.06 million -5.5%15.7%23.2 $9.67
6/15/20224,930,000 shares $37.76 million -13.7%16.6%23.6 $7.66
5/31/20225,710,000 shares $44.20 million +1.1%19.3%22.2 $7.74
5/15/20225,650,000 shares $46.27 million -0.2%19.1%21 $8.19
4/30/20225,660,000 shares $61.69 million -1.9%19.1%20.4 $10.90
4/15/20225,770,000 shares $78.88 million -3.4%19.5%18.9 $13.67
3/31/20225,970,000 shares $83.70 million +10.8%N/A18.9 $14.02
3/15/20225,390,000 shares $75.24 million +8.0%18.3%17.1 $13.96
2/28/20224,990,000 shares $71.56 million +10.9%16.9%21.1 $14.34
2/15/20224,500,000 shares $65.16 million +32.0%15.3%20.1 $14.48
1/31/20223,410,000 shares $43.17 million -3.1%11.6%17 $12.66
1/15/20223,520,000 shares $52.80 million +5.4%N/A21 $15.00
12/31/20213,340,000 shares $68.20 million +3.4%11.3%22.7 $20.42
12/15/20213,230,000 shares $59.79 million +17.0%11.0%23.4 $18.51
11/30/20212,760,000 shares $53.52 million +9.1%9.4%15.8 $19.39
11/15/20212,530,000 shares $58.19 million -0.4%8.6%13.7 $23.00
10/29/20212,540,000 shares $59.56 million +5.8%9.3%12.8 $23.45
10/15/20212,400,000 shares $50.88 million -5.1%8.8%11.5 $21.20
9/30/20212,530,000 shares $56.37 million +30.4%9.3%11.2 $22.28
9/15/20211,940,000 shares $62.82 million +12.8%7.1%6.1 $32.38
8/31/20211,720,000 shares $61.39 million +44.5%6.5%5.8 $35.69
8/13/20211,190,000 shares $40.25 million No Change5.9%3.8 $33.82

GLUE Short Interest - Frequently Asked Questions

Short interest is the volume of Monte Rosa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 14,962,299 shares of GLUE short. 18.92% of Monte Rosa Therapeutics' shares are currently sold short. Learn More on Monte Rosa Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLUE shares currently have a short interest ratio of 20.6. Learn More on Monte Rosa Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.92% of Monte Rosa Therapeutics' floating shares are currently sold short.

Monte Rosa Therapeutics saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 14,962,299 shares, a decrease of 1.2% from the previous total of 15,142,638 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.92% of Monte Rosa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Monte Rosa Therapeutics: Spyre Therapeutics, Inc. (16.96%), Lantheus Holdings, Inc. (10.06%), Rhythm Pharmaceuticals, Inc. (12.84%), Mirum Pharmaceuticals, Inc. (15.70%), TG Therapeutics, Inc. (20.55%), Centessa Pharmaceuticals PLC Sponsored ADR (1.72%), Scholar Rock Holding Corporation (15.08%), Cogent Biosciences, Inc. (7.04%), PTC Therapeutics, Inc. (13.06%), CG Oncology, Inc. (10.93%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling GLUE is an investing strategy that aims to generate trading profit from Monte Rosa Therapeutics as its price is falling. GLUE shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Monte Rosa Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLUE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLUE, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GLUE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:GLUE) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel